REGENERX BIOPHARMACEUTICALS, INC. Contract Liability (Deferred Revenue)
REGENERX BIOPHARMACEUTICALS, INC. had Contract Liability (Deferred Revenue) of $76.76 thousand as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2023-05-15
- 2023-03-31: Contract with Customer, Liability, Current $76.76K.
- 2022-12-31: Contract with Customer, Liability, Current $76.76K.
- 2022-09-30: Contract with Customer, Liability, Current $76.76K.
- 2022-06-30: Contract with Customer, Liability, Current $76.76K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2023-03-31 | $76.76K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $76.76K 10-Q · filed 2023-05-15 |
| 2022-09-30 | $76.76K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $76.76K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $76.76K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $76.76K 10-K · filed 2023-04-11 |
| 2021-09-30 | $76.76K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $76.76K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $76.76K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $76.76K 10-K · filed 2022-03-30 |
| 2020-09-30 | $76.76K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $76.76K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $76.76K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $76.76K 10-K · filed 2021-03-02 |
| 2019-09-30 | $76.76K 10-Q · filed 2019-11-14 |
| 2018-12-31 | $76.76K 10-K · filed 2020-03-20 |